Back To: Home

Our 2019 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
February 2019
Bristol-Myers Squibb aims to acquire Celgene for a hefty $74 billion...
by Kelsey Kaustinen
February 2019
Insight into how Ebola, Dengue and Zika viruses interact with human cells opens the door for treatments...
by Mel J. Yeates
February 2019
New liquid biopsy technique a powerful diagnostic tool for early detection of ovarian, endometrial cancer...
by Lori Lesko
February 2019
AI is becoming far less of a buzzword and much more of a practical and necessary reality...
by Jeffrey Bouley

Patent Docs:
Obviousness remains an uncertain patentability standard
Public policy regarding innovator drug products need regulatory exclusivities outside mere patent protection in order to provide necessary incentive for further pharmaceutical innovation

Editor's Focus:
February 2019
There are currently three main approaches to characterizing the immune landscape of solid tumors: transcriptional profiling, single-cell cytometric analyses and histology; each of these disciplines brings its own benefits and, with rapid technological advances, powerful datasets are now achievable... [ more ]
by S. Anderton and M. Millar

February 2019
We have seen information technology anxiety run rampant in the past (with Y2K); today's worries about cyber security, fake news, autonomous robotics and artificial intelligence are nothing new...but they are worth noting nonetheless.. [ more ]
by Peter T. Kissinger

February 2019
Well, if nothing else, artificial intelligence may be about to surpass the intelligence of many of today's politicians; let's talk a little bit about both.. [ more ]
by Jeffrey Bouley

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.